These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 1880127

  • 1. Examination of aglycone-binding site of human salivary alpha-amylase by means of transglycosylation reactions.
    Omichi K, Hase S, Ikenaka T.
    J Biochem; 1991 Mar; 109(3):410-5. PubMed ID: 1880127
    [Abstract] [Full Text] [Related]

  • 2. Investigation of the active site of Bacillus macerans cyclodextrin glucanotransferase by use of modified maltooligosaccharides.
    Abe S, Nagamine Y, Omichi K, Ikenaka T.
    J Biochem; 1991 Nov; 110(5):756-61. PubMed ID: 1838375
    [Abstract] [Full Text] [Related]

  • 3. Inspection of human salivary alpha-amylase action by its transglycosylation action.
    Omichi K, Ikenaka T.
    J Biochem; 1988 Dec; 104(6):881-3. PubMed ID: 3266624
    [Abstract] [Full Text] [Related]

  • 4. Studies on the active site of human alpha-amylases: examination of the third subsite S3' of the aglycone-binding site by control of substrate binding mode.
    Omichi K, Hase S, Ikenaka T.
    J Biochem; 1992 Jan; 111(1):4-7. PubMed ID: 1607363
    [Abstract] [Full Text] [Related]

  • 5. Investigation of the active site of human salivary alpha-amylase from the modes of action on modified maltooligosaccharides.
    Nagamine Y, Omichi K, Ikenaka T.
    J Biochem; 1988 Sep; 104(3):409-15. PubMed ID: 3266496
    [Abstract] [Full Text] [Related]

  • 6. Actions of three human alpha-amylases expressed in yeast on modified substrates and the amino acid residues causing their different actions.
    Omichi K, Shiosaki K, Matsubara K, Ikenaka T.
    J Biochem; 1989 Oct; 106(4):646-50. PubMed ID: 2691509
    [Abstract] [Full Text] [Related]

  • 7. Differential rate assay of human pancreatic and salivary alpha-amylases in serum using two coupled enzymes.
    Omichi K, Ikenaka T.
    J Biochem; 1986 Nov; 100(5):1353-8. PubMed ID: 3546280
    [Abstract] [Full Text] [Related]

  • 8. Studies on the active site of Taka-amylase A: its action on phenyl maltooligosides with a charge at their non-reducing-ends.
    Nagamine Y, Sumikawa M, Omichi K, Ikenaka T.
    J Biochem; 1987 Oct; 102(4):767-75. PubMed ID: 3501785
    [Abstract] [Full Text] [Related]

  • 9. Inspection of active sites of human salivary alpha-amylase isozymes by means of non-reducing-end substituted maltooligosaccharides with 2-pyridylamino residue.
    Omichi K, Ikenaka T.
    J Biochem; 1986 Apr; 99(4):1245-52. PubMed ID: 3486866
    [Abstract] [Full Text] [Related]

  • 10. Difference in transglycosylation between human pancreatic and salivary alpha-amylases.
    Omichi K, Ikenaka T.
    J Biochem; 1983 Dec; 94(6):1797-802. PubMed ID: 6608517
    [Abstract] [Full Text] [Related]

  • 11. Examination of the active sites of human salivary alpha-amylase (HSA).
    Kandra L, Gyémánt G.
    Carbohydr Res; 2000 Nov 17; 329(3):579-85. PubMed ID: 11128586
    [Abstract] [Full Text] [Related]

  • 12. Detection of human urinary alpha-amylase encoded by the AMY2B gene using a fluorogenic substrate, FG5P.
    Omichi K, Hase S.
    J Biochem; 1992 Sep 17; 112(3):303-5. PubMed ID: 1429515
    [Abstract] [Full Text] [Related]

  • 13. Introducing transglycosylation activity into human salivary alpha-amylase (HSA).
    Remenyik J, Ragunath C, Ramasubbu N, Gyémánt G, Lipták A, Kandra L.
    Org Lett; 2003 Dec 11; 5(25):4895-8. PubMed ID: 14653701
    [Abstract] [Full Text] [Related]

  • 14. Differentiation of human non-salivary, non-pancreatic alpha-amylase from salivary and pancreatic alpha-amylases by use of FG5P.
    Omichi K, Shiosaki K, Matsubara K, Ikenaka T.
    J Biochem; 1990 Apr 11; 107(4):546-9. PubMed ID: 2358428
    [Abstract] [Full Text] [Related]

  • 15. Alpha-amylase assay with use of a benzyl derivative of p-nitrophenyl alpha-maltopentaoside, BG5P.
    Satomura S, Sakata Y, Omichi K, Ikenaka T.
    Clin Chim Acta; 1988 Jun 15; 174(3):315-23. PubMed ID: 3134147
    [Abstract] [Full Text] [Related]

  • 16. Preparation of non-reducing-end substituted p-nitrophenyl alpha-maltopentaoside (FG5P) as a substrate for a coupled enzymatic assay for alpha-amylases.
    Omichi K, Ikenaka T.
    J Biochem; 1985 Apr 15; 97(4):977-82. PubMed ID: 3161874
    [Abstract] [Full Text] [Related]

  • 17. Subsite mapping of human salivary alpha-amylase and the mutant Y151M.
    Kandra L, Gyémánt G, Remenyik J, Ragunath C, Ramasubbu N.
    FEBS Lett; 2003 Jun 05; 544(1-3):194-8. PubMed ID: 12782315
    [Abstract] [Full Text] [Related]

  • 18. Differential assay of human pancreatic and salivary alpha-amylases in serum using a new fluorogenic substrate.
    Omichi K, Ikenaka T.
    Clin Chim Acta; 1984 Apr 13; 138(2):197-203. PubMed ID: 6609786
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the modes of actions of human salivary and pancreatic alpha-amylases on modified maltooligosaccharides.
    Nagamine Y, Omichi K, Ikenaka T.
    J Biochem; 1988 Oct 13; 104(4):667-70. PubMed ID: 2467909
    [Abstract] [Full Text] [Related]

  • 20. Syntheses of subtractively modified 2-chloro-4-nitrophenyl beta-maltopentaosides and their application to the differential assay of human alpha-amylases.
    Tokutake S, Oguma T, Tobe K, Kotani K, Saito K, Yamaji N.
    Carbohydr Res; 1993 Jan 15; 238():193-213. PubMed ID: 8431933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.